Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML
- Resource Type
- Article
- Authors
- Menghrajani, Kamal ; Gomez-Arteaga, Alexandra; Madero-Marroquin, Rafael; Zhang, Mei-Jie; Bo-Subait, Khalid; Sanchez, Jonathan; Wang, Hai-Lin; Aljurf, Mahmoud; Assal, Amer; Bacher, Vera Ulrike; Badawy, Sherif M.; Bejanyan, Nelli; Bhatt, Vijaya Raj; Bredeson, Christopher; Byrne, Michael; Castillo, Paul; Cerny, Jan; Chhabra, Saurabh; Ciurea, Stefan Octavian; DeFilipp, Zachariah; Farhadfar, Nosha; Gadalla, Shahinaz; Gale, Robert Peter; Ganguly, Siddhartha; Gowda, Lohith; Grunwald, Michael R.; Hashmi, Shahrukh; Hildebrandt, Gerhard; Kanakry, Christopher G.; Kansagra, Ankit; Khimani, Farhad; Krem, Maxwell; Lazarus, Hillard; Liu, Hongtao; Martino, Rodrigo; Michelis, Fotios V.; Nathan, Sunita; Nishihori, Taiga; Olsson, Richard; Reshef, Ran; Rizzieri, David; Rowe, Jacob M.; Savani, Bipin N.; Seo, Sachiko; Sharma, Akshay; Solh, Melhem; Ustun, Celalettin; Verdonck, Leo F.; Hourigan, Christopher; Sandmaier, Brenda; Litzow, Mark; Kebriaei, Partow; Weisdorf, Daniel; Zhang, Yanming; Tallman, Martin S.; Saber, Wael
- Source
- In Blood Advances 8 February 2022 6(3):828-847
- Subject
- Language
- ISSN
- 2473-9529